Keyphrases
Adjusted Odds Ratio
13%
Allergic Diseases
20%
Antiretroviral Therapy
26%
Asia
20%
Autoimmune Disease
40%
Behavioral Model
20%
BioNTech
13%
CD4 Count
14%
Confidence Interval
13%
Consensus Guidelines
20%
Coronavirus Disease 2019 Vaccine
20%
CoV-2
20%
COVID-19
25%
COVID-19 Infection
27%
COVID-19 Pandemic
20%
COVID-19 Vaccination
17%
COVID-19 Vaccination Intention
20%
COVID-19 Vaccine
64%
Everyday Practices
20%
First-line Antiretroviral Therapy
20%
Healthcare Workers
20%
Healthy Population
20%
Hereditary Angioedema
20%
High Risk
37%
HIV Outcomes
20%
Hospitalization
20%
Immune System
20%
Immunogenicity
26%
Indonesia
100%
Influenza
20%
Influenza Vaccination
20%
Integrated Behavioral Model
16%
Integrative Behavior
20%
Knowledge Conditions
20%
Knowledge-attitude-behavior
20%
Meta-analysis
20%
Nationwide Survey
20%
Observational Database
20%
Patients with Diabetes
20%
Patients with Diabetes Mellitus
20%
People Living with HIV (PLHIV)
32%
Pfizer
13%
Provocation Test
20%
Reintroduction
13%
Socioeconomic Conditions
20%
Systematic Meta-analysis
20%
Tertiary Hospital
20%
Unplanned Interruptions
20%
Virological Outcome
20%
Virological Success
13%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Allergic Reaction
17%
Angioneurotic Edema
20%
Autoimmune Disease
40%
Cardiovascular Disease
5%
CD8 Antigen
6%
Clinical Trial
5%
Coronavirinae
20%
COVID-19 Vaccine
60%
Cross-Sectional Study
20%
Disease
23%
HIV
20%
Immunogenicity
45%
Immunosuppressive Agent
6%
Infection
27%
Intervention Study
5%
Mortality Rate
5%
Neutralizing Antibody
24%
Pandemic
26%
Placebo
5%
Prednisone
5%
Prevalence
5%
Provocation Test
20%
Recombinant Vaccine
25%
Retrospective Study
22%
Safety Assessment
6%
SARS Coronavirus
30%
Vaccination Policy
29%
Vaccine
17%
Vaccine Development
10%
Viral Vector
5%
Immunology and Microbiology
Adoptive Immunity
5%
Antibody Titer
5%
Autoimmune Disease
40%
COVID-19
63%
Face
5%
Glucose Blood Level
5%
Hypersensitive Response
14%
Immune System
10%
Immunogenicity
40%
Influenza
20%
Neutralizing Antibody
7%
Protein Subunit
20%
Seroconversion
8%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Synthetic Vaccine
20%
T Cell
5%
Vaccination Policy
34%
Vaccine Efficacy
60%
